CG. Langdon (1), N. Wiedemann (2), M. Held (1), J. Platt (1), F. Lévy (2), C. Zann, G. Vuagniaux (2), M. Sorensen (3), S. Wang (4), M. Bosenberg (1), DF. Stern (1)
presented at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
(1) Yale University, USA
(2) Debiopharm International SA, Switzerland
(3) Ascenta Therapeutics, USA
(4) University of Michigan Cancer Center, USA